Merck & Co Q3 Adj. EPS $2.49 Beats $2.08 Estimate, Sales $18.085B Beat $17.313B Estimate
Benzinga Newsdesk 4 days ago
NewsEarningsHotEarnings Beats
Merck & Co (NYSE:MRK) reported quarterly earnings of $2.49 per share which beat the analyst consensus estimate of $2.08 by 19.71 percent. This is a 3.49 percent decrease over earnings of $2.58 per share from the
Merck & Co (NYSE:MRK) reported quarterly earnings of $2.49 per share which beat the analyst consensus estimate of $2.08 by 19.71 percent. This is a 3.49 percent decrease over earnings of $2.58 per share from the same period last year. The company reported quarterly sales of $18.085 billion which beat the analyst consensus estimate of $17.313 billion by 4.46 percent. This is a 4.68 percent increase over sales of $17.276 billion the same period last year.